Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Avenue Therapeutics Inc. buy BiotechBee

Avenue Therapeutics Inc.
Start price
€0.18
02.12.23 / 50%
Target price
€0.35
02.12.24
Performance (%)
-28.97%
End price
€0.13
17.02.24
Summary
This prediction ended on 17.02.24 with a price of €0.13. The price of Avenue Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.97%. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Avenue Therapeutics Inc. - - -
iShares Core DAX® -0.046% 5.960% 7.403%
iShares Nasdaq 100 0.922% 3.693% 28.138%
iShares Nikkei 225® 3.014% 6.638% 48.886%
iShares S&P 500 -0.359% 2.747% 22.530%

According to BiotechBee what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Avenue Therapeutics diskutieren
Prediction Buy
Perf. (%) -28.97%
Target price 0.350
Change
Ends at 02.12.24

Buy mit Kursziel 0,35

BiotechBee 
0
Report Share
02.12.23
In the thread Trading Avenue Therapeutics
Prediction Buy
Perf. (%) -28.97%
Target price 0.350
Change
Ends at 02.12.24

Buy beendet

BiotechBee 
0
Report Share
17.02.24